Last reviewed · How we verify
A Double-blind, Double-dummy, Multi-centre, Randomized, Active Controlled, Parallel Group Pilot Trial to Compare the Effects of Valsartan and Atenolol on the Pro-thrombotic State in Patients With Mild to Moderate Hypertension.
A study to compare the effects of Diovan or Atenolol taken for 12 weeks on platelet function of patients who have mild to moderately severe hypertension
Details
| Lead sponsor | Novartis |
|---|---|
| Phase | Phase 4 |
| Status | COMPLETED |
| Enrolment | 92 |
| Start date | 2004-06 |
| Completion | 2006-03 |
Conditions
- Hypertension
Interventions
- valsartan/atenolol
Primary outcomes
- Change from baseline in a clinical laboratory measurement of a blood clotting factor after 12 weeks
Countries
Switzerland